Algeria Algeria’s key macroeconomic and healthcare indicators. Cardiovascular disease prevalence in North Africa. Diabetes prevalence in North Africa. The rate of change in the number of years of healthy life lost to obesity in Africa. Click here to download the latest roundtable discussion on Algerian healthcare.
Algeria A high-level civil servant at the ministry for labour explains in depth the social welfare system in Algeria and specifically how pharmaceutical products are registered and the mechanism for state reimbursement of medicines. Can you please start by introducing the social security system in Algeria, highlighting those features that make…
Algeria Arnaud de Rincquesen – Managing Partner, Deloitte: Companies are willing to come to Algeria. It’s an interesting market. What matters once again is to have a job market. The biggest issue for a company settling in Algeria is to find peo- ple with specialized skills and a good academic level.…
Algeria PharmaBoardroom recently conducted a roundtable event with the key opinion leaders of Algeria’s healthcare sector. This is a sample of the conversation at our recent roundtable. Algeria’s youthful pharmaceutical landscape includes an array of state-controlled entities of an industrial or commercial nature alongside more conventional regulatory apparatus. THE NATIONAL AGENCY FOR…
Algeria
diabetes
Ferring The country manager of a research-driven, specialty biopharmaceutical group offering treatments for infertility outlines his firm’s approach for the socially conservative Algerian market. Your promotion as general manager of Ferring Algeria is quite recent. Can you tell us what were your priorities during the first year and how do you…
See our Cookie Privacy Policy Here